Authors: Meltzer, EO Prenner, BM Nayak, A

Citation: Eo. Meltzer et al., Efficacy and tolerability of once-daily 5mg desloratadine, an H-1-receptorantagonist, in patients with seasonal allergic rhinitis - Assessment during the spring and fall allergy seasons, CLIN DRUG I, 21(1), 2001, pp. 25-32

Authors: Prenner, BM

Citation: Bm. Prenner, The evolution of pharmacotherapy for rhinitis and urticaria, ALL ASTH P, 22(5), 2001, pp. 277-280

Authors: Fireman, P Prenner, BM Vincken, W Demedts, M Mol, SJM Cohen, RM

Citation: P. Fireman et al., Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol, ANN ALLER A, 86(5), 2001, pp. 557-565

Authors: Prenner, BM Capano, D Harris, AG

Citation: Bm. Prenner et al., Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A double-blind comparison with crossover treatment of nonresponders, CLIN THER, 22(6), 2000, pp. 760-769

Authors: Meltzer, EO Malmstrom, K Lu, S Prenner, BM Wei, LX Weinstein, SF Wolfe, JD Reiss, TF

Citation: Eo. Meltzer et al., Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial, J ALLERG CL, 105(5), 2000, pp. 917-922